Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Home About Us My Account Personal Library Customer Service    
Welcome Guest
(login/register)
US: 800.298.5699
Int'l: +1.240.747.3093
Quick Search
Advanced Search >
Research Assistance
Send us a request >
Latest Research by Email
Receive email alerts of new market research reports in your industry.
Sign Up Today >
Home > Back to Publisher > Report Information Email a colleague | Printer format

Antibiotics: Global Anti-Infectives Markets Vol. II

PJB Publications USA Inc.
May 1, 2004
414 Pages - Pub ID: VB999181
 
Questions about this report >
Order by fax >
XE.com
Abstract

Table of
Contents
Search Inside
this Report
Related Reports


Countries covered: Global

Antibiotics: Global Anti-Infectives Markets Vol. II

 
Second volume in Theta’s three-part anti-infectives report series...

Theta’s in-depth analysis will provide you with:

  • Global market analysis of a dozen antibiotic drug classes
  • 2008 market size and growth projections
  • Comprehensive overviews of major antibiotic drug classes
  • Coverage of latest research and development activities
  • Company briefs of leading and up-and-coming pharmaceutical firms

Major classes of antibiotic drugs included:

  • Sulphonamides
  • Penicillins
  • Tetracyclines
  • Cephalosporines
  • Cephems
  • Aminoglycosides
  • Macrolides
  • Glycopeptides
  • Quinolones
  • Carbapenems
  • Oxazolidinones
  • Streptogramins

An essential strategic resource, Theta’s Antibiotics: Global Anti-Infectives Markets Vol. II answer the following questions:

  • What conditions currently require treatment with antibiotics?
  • What types of antibiotics are available to treat these conditions?
  • How do the various classes of antibiotics differ?
  • What is the current market for antibiotic drugs by class?
  • What are the competitive positions of the major players in the antibiotic market?
  • What new antibiotics are currently in development?
  • What are the key issues facing developers of antibiotic drugs now?



Please Note: Theta requires that, for PDF orders, clients sign a confidentiality agreement prior to fulfillment of PDF email delivery.

Related Reports:
U.S. Overactive Bladder Market
Snapshots US Pharmaceuticals 2009
Mapping the Healthcare Landscape Bringing pharmaceuticals into focus
Pharmaceutical Industry in the United States - Porter’s Five Forces Strategy Analysis
Pharmaceuticals Industry Report
Opportunity Analysis of H1N1 (swine flu) Vaccination Market
Pharmaceutical Industry in Mexico
Infectious Disease Testing Market: US, Europe, Japan--Emerging Opportunities and Business Strategies
CDK Inhibitors Patent Landscape 2009
Antipsychotics Market Forecast

Privacy Policy    |    Terms and Conditions    |    Site Map    |    Return Policy    |    Press    |    Help FAQs
Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2009, All Rights Reserved, MarketResearch.com
11/24/2009 - 3